The global burden of cardiovascular disease morbidity and mortality demands increased awareness of effective prevention strategies by patients, communities and health-care providers. The new 2019 ACC/AHA guidelines provide evidence-based, preventive recommendations for patients without known cardiovascular disease, focusing on risk estimation, a healthy lifestyle and selective indications for pharmacotherapy.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $17.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Roth, G. A. et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J. Am. Coll. Cardiol. 70, 1–25 (2017).
Shah, B. et al. Temporal trends in clinical characteristics of patients without known cardiovascular disease with a first episode of myocardial infarction. Am. Heart. J. 167, 480–488 (2014).
Myerburg, R. J. Sudden cardiac death: exploring the limits of our knowledge. J. Cardiovasc. Electrophysiol. 12, 369–381 (2001).
Arnett, D. K. et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J. Am. Coll. Cardiol. https://doi.org/10.1161/CIR.0000000000000677 (2019).
Benjamin, E. J. et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 135, e146–e603 (2017).
Orrow, G. et al. Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials. BMJ 344, e1389 (2012).
Kelli, H. M. et al. Living in food deserts and adverse cardiovascular outcomes in patients with cardiovascular disease. J. Am. Heart. Assoc. 8, e010694 (2019).
McLean, D. L. et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch. Intern. Med. 168, 2355–2361 (2008).
Cardoso, R. et al. Selective use of coronary artery calcium testing for shared decision making: guideline endorsed and ready for prime time. Ann. Intern. Med. 170, 262–263 (2019).
Nasir, K. et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 66, 1657–1668 (2015).
The authors declare no competing interests.